Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?-Reference-Cited by-同舟云学术

Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?

Published:2015-11-05 Issue:5 Volume:103 Page:560-566
ISSN:0028-3835
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

van Adrichem Roxanne C.S.,Kamp Kimberly,van Deurzen Carolien H.M.,Biermann Katharina,Feelders Richard A.,Franssen Gaston J.H.,Kwekkeboom Dik J.,Hofland Leo J.,de Herder Wouter W.

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic marker of immunohistochemistry-based somatostatin receptors 2 and 5 H-scores in patients with pancreatic neuroendocrine neoplasms;Endocrine and Metabolic Science;2024-06

2. Workup of Newly Diagnosed NENs;Endocrinology;2024

3. Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology (BGDO) and supported by the BGDO, the BSP (Belgian Society of Pathology) and the BCR (Belgian Cancer Registry);Acta Gastro Enterologica Belgica;2023-06

4. The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports;Endocrine Pathology;2023-05-11

5. Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines;Cancers;2022-12-31